Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Many older people have biomarkers indicative of a strong response to checkpoint inhibitors.
The ExoGrail test could help reduce the need for invasive biopsies.
A new study has found that a microRNA may help drive the transition from normal fallopian tube cells to cancer in the ovary.
A novel liquid biopsy method can detect kidney cancers with high accuracy, including small, localized tumors which are often curable.
This could result in better identification of the people who could benefit from screening and early detection of pancreatic cancer.
Biomarker was not linked to response rates in two studies of Keytruda for lung cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.